Plby Group Inc vs Health Care Select Sector SPDR Fund — how do they compare? Plby Group Inc trades at $0.97 (market cap $118.21M), while Health Care Select Sector SPDR Fund trades at $170.76 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 367.8× Plby Group Inc's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Plby Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Plby Group Inc for 24 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| PLBY | XLV | |
|---|---|---|
Market Cap | $118.21M | $43.48B |
Volume | 919,783 | 11,121,431 |
Sector | Consumer Cyclical | — |
52-Week High | $2.71 | $175.68 |
52-Week Low | $0.99 | $141.95 |
Typical Hold Time | 24 Days | 100 Days |
Enterprise Value | $263.80M | — |
Signals from Pluang's Aura AI — not financial advice
PLBY Group trades at $0.97, down 4.5% today, with a bearish technical outlook despite analyst optimism. The company shows improving fundamentals with revenue stabilizing around $120M and narrowing losses, though it remains unprofitable with negative equity. Recent leadership appointments signal strategic focus on brand growth and licensing expansion.
The stock presents a turnaround opportunity with strong analyst support (75% buy ratings) but carries significant risk from high debt levels and negative shareholder equity. Near-term catalysts depend on execution of the media and experiences strategy, while competitive pressures and cash flow volatility remain concerns.
XLV trades at $170.86, up 1.21% with a bearish technical signal from moving averages while oscillators remain neutral. The healthcare ETF shows strong cost advantages with a 0.08% expense ratio compared to peers, holding 61 diversified healthcare stocks from the S&P 500. Recent news highlights XLV's defensive characteristics during potential Fed rate hikes and political volatility.
The ETF offers defensive exposure to healthcare with low costs, though technical indicators suggest near-term pressure. Key risks include sector-specific regulatory changes and election uncertainty, while the fund's diversification provides stability amid market volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.
Read more on PLBY →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →